1 PERSISTENT PAIN 2 OBJECTIVES • List the 3 major types of pain syndromes • Identify components of a thorough pain assessment • Recognize common pain behaviors in cognitively impaired older people • Gain an initial understanding of the principles underlying nonpharmacologic and pharmacologic treatment of persistent pain • Describe how to manage the adverse effects of opioids 3 TO P I C S C O V E R E D • Assessment • Assessing and Treating Pain in Cognitively Impaired People • Treatment Fundamental Approaches Barriers to Using Opioids in Older People Adverse Effects of Opioids Nonopioid Medication to Treat Persistent Pain Medications to Avoid in Older People PREVALENCE OF PERSISTENT PAIN IN OLDER PEOPLE Substantial pain is experienced by: 25% to 50% of community-dwelling older adults 45% to 80% of nursing-home residents 4 5 PAIN IS COMMONLY UNDERTREATED • Patients may: Minimize their symptoms Not report pain Be unable to report pain because of limited English proficiency or cognitive impairment • Clinicians may: Inadequately assess pain Undertreat pain with ineffective therapies Encounter intolerable adverse effects with otherwise effective therapies 6 INITIAL ASSESSMENT • Take a complete history of the pain Character Course of its onset Duration Location • Carefully evaluate patient’s baseline functional status ( before initiating any therapy and compare to post treatment functional status) • Evaluate patient’s cognitive state, participation in social activities, mood, and quality of life 7 PAIN INTENSITY SCALES • Unidimensional scales: Numeric Rating Scale—0 is no pain, 10 is worst pain imaginable Faces Pain Scale—patient chooses a facial expression that corresponds to the pain Verbal Descriptor Scale—“no pain” to “pain as bad as it could be” • Multidimensional scales: McGill Pain Questionnaire Pain Disability Scale 8 PAIN MAP • Ask patient to indicate the locations of their pain on a drawing of a human figure • Consider referral to a mental health specialist (to evaluate for affective disorder contributing to the discomfort) if the patient’s pain pattern: Is erratic Is diffuse Does not conform to an anatomic distribution 9 PHYSICAL EXAMINATION • Carefully examine the reported site of pain and locations that may be a source of referred pain • Perform complete musculoskeletal exam Fibromyalgia, osteoarthritis, or myofascial pain is commonly either the primary source of pain or an exacerbating process Accurate diagnosis is critical to formulating the correct therapeutic plan 10 3 TYPES OF PAIN SYNDROMES • Nociceptive—pain due to activation of nociceptive sensory receptors; often adequately treated with common analgesics Somatic—well localized in skin, soft tissue, bone Visceral—due to cardiac, GI, or lung injury • Neuropathic—from irritation of components of the CNS or peripheral nervous system; may respond well to nonopioid therapies; responds unpredictably to opioids • Mixed or unspecified—has characteristics of both nociceptive and neuropathic pain; common in older adults 11 NOCICEPTIVE PAIN Examples Source of pain Table 15.1 Typical description Effective drug classes and nonpharmacologic treatments Nociceptive: somatic Arthritis, bone metastases Tissue injury Well localized, constant; (eg, bones, soft aching, stabbing, tissue, joints, gnawing, throbbing muscles) Acetaminophen, opioids Physical and cognitivebehavioral therapies Nociceptive: visceral Renal colic, constipation Viscera Diffuse, poorly localized, referred to other sites, intermittent, paroxysmal; dull, colicky, squeezing, deep, cramping; often accompanied by nausea, vomiting, diaphoresis Treatment of underlying cause Physical and cognitivebehavioral therapies 12 NEUROPATHIC PAIN Examples Table Source of 15.1 pain Cervical or lumbar radiculopathy, post-herpetic neuralgia, trigeminal neuralgia, diabetic neuropathy, poststroke syndrome, herniated intervertebral disc Peripheral or central nervous system Typical description Prolonged, usually constant, but can have paroxysms; sharp, burning, pricking, tingling, squeezing; associated with other sensory disturbances (eg, paresthesias and dysesthesias); allodynia, hyperalgesia, impaired motor function, atrophy, or abnormal deep tendon reflexes Effective drug classes and nonpharmacologic treatments Tricyclic antidepressants, anticonvulsants, serotoninnorepinephrine reuptake inhibitor antidepressants, opioids, topical anesthetics Physical and cognitivebehavioral therapies 13 UNDETERMINED PAIN Examples Table 15.1 Myofascial pain syndrome, somatoform pain disorders Source of pain Poorly understood Typical description No identifiable pathologic processes or symptoms out of proportion to identifiable organic pathology; widespread musculoskeletal pain, stiffness, and weakness Effective drug classes and nonpharmacologic treatments Antidepressants, antianxiety agents Physical, cognitivebehavioral and psychological therapies PAIN IN COGNITIVELY IMPAIRED PEOPLE • Observe for possible pain-related behaviors (see next slides) and ask caregivers for their observations Consider trial of analgesia for patients exhibiting pain-related behaviors • Validated scales (eg, Hurley Discomfort Scale, Checklist of Nonverbal Pain Indicators) require training Provide empiric analgesia during procedures and conditions known to be painful 14 15 COMMON PAIN BEHAVIORS IN COGNITIVELY IMPAIRED OLDER ADULTS (1 of 2) Behavior Examples Facial expressions • • • • Slight frown; sad, frightened face Grimacing, wrinkled forehead, closed/tightened eyes Any distorted expression Rapid blinking Verbalizations, vocalizations • • • • • Sighing, moaning, groaning Grunting, chanting, calling out Noisy breathing Asking for help Verbal abusiveness Body movements • • • • • Rigid, tense body posture, guarding Fidgeting Increased pacing, rocking Restricted movement Gait or mobility changes 16 COMMON PAIN BEHAVIORS IN COGNITIVELY IMPAIRED OLDER ADULTS (2 of 2) Behavior Examples Changes in interpersonal interactions • • • • Aggressive, combative, resists care Decreased social interactions Socially inappropriate, disruptive Withdrawn Changes in activity patterns or routines • • • • • Refusing food, appetite change Increase in rest periods Sleep, rest pattern changes Sudden cessation of common routines Increased wandering Mental status changes • Crying or tears • Increased confusion • Irritability or distress 17 NONPHARMACOLOGIC THERAPIES • Patient education and involvement in decisions Teach patients to take medications properly and how to use assessment instruments Give partner-guided pain management training to caregivers • Cognitive-behavioral therapy • Regular physical activity Or supervised rehabilitation for frail patients, or regular repositioning and gentle massage for bed-bound patients • Referral to an interdisciplinary pain clinic PRINCIPLES OF PHARMACOLOGIC THERAPY • Besides pain relief, the goals are improved function and enhanced adherence with rehabilitation • Individualize the initial dose and rate of titration • In general, start opioids at lowest dose and titrate slowly, but if patient is in pain crisis, do not withhold medications • Try nonsystemic or nonpharmacologic therapies first if appropriate 18 TREATING MILD TO MODERATE PAIN: ACETAMINOPHEN • Particularly for musculoskeletal pain • No more than 4 g every 24 hours • Lower the dose by 50%, or avoid, in patients at risk of liver dysfunction, especially with history of heavy alcohol intake • Know all medications the patient is taking, as acetaminophen is a common ingredient in prescription and OTC drugs 19 20 TREATING MILD TO MODERATE PAIN: NSAIDs • Many significant adverse effects • Use selective COX-2 inhibitor with extreme caution, if at all, in older people. Only celecoxib is available currently ( 2013). • Use judiciously, if at all, only after acetaminophen has been tried and only in highly select individuals 21 TREATING MODERATE TO SEVERE PAIN • To estimate opioid requirements, conduct a trial of a short-acting opioid ( start low and go slow) • Treat continuous pain with 24-hour opioids in longacting or sustained-release formulations To cover breakthrough pain, combine with fast-onset medications that have short half-lives Breakthrough pain typically requires 5%–15% of the daily dose, offered q2 to q4h orally • In general, different opioids are similarly efficaciouschoice of opioid is based on side effect profile. 22 USING OPIOIDS IN RENAL FAILURE • Avoid morphine, as its metabolites accumulate; if it must be used, increase the dosing interval and reduce the dose • Safety of oxycodone in older adults has not be studied well but clinical practice shows that it is safer than morphine in patients with renal dysfunction. • Hydromorphone is an acceptable choice for older adults, but start slow and go slow as there are no sustained-release formulations currently ( 2013) • Low-dose methadone is reasonable as metabolized in the liver and excreted thru feces COMBATTING FEAR OF TOLERANCE AND ADDICTION TO OPIOIDS • Avoid withdrawal symptoms by tapering carefully over days to weeks • If rapid upward titration is required to reduce pain, evaluate the cause of pain: Search for new pathologies, exacerbation of known sources Consider nonphysical causes of pain • There is partial cross-tolerance between opioids When from one opioid to another, reduce the dose of the new drug by 50%–65% of the equianalgesic dose 23 MANAGING THE ADVERSE EFFECTS OF OPIOIDS (1 of 2) • Constipation Educate patient about probable need for long-term laxative treatment In most cases, start with a stimulant laxative Encourage exercise and hydration Consider methylnaltrexone for patients with severe opioid-induced constipation despite maximal laxative therapy • Nausea and vomiting—evaluate for reversible causes such as constipation; short-acting opioids are more likely to cause nausea 24 MANAGING THE ADVERSE EFFECTS OF OPIOIDS (2 of 2) • Sedation, fatigue, mild cognitive impairment Educate the patient and caregiver that these changes generally subside days to weeks after dose adjustment Warn against driving or operating heavy equipment when medication is initiated Warn of the risk of falls Severe sedation or fatigue: try a stimulant such as lowdose methylphenidate or rotation to a different opioid • Respiratory depression—use naloxone sparingly, at the lowest dose, and titrate carefully 25 26 NONOPIOID MEDICATION (1 of 2) • Tricyclic antidepressants (off-label) are the best-studied drugs for neuropathic pain Avoid amitriptyline in older adults Use imipramine, desipramine, or nortryptamine • Optimal analgesia requires treatment of depression SSRIs are less well studied than TCAs as analgesics, but they are better tolerated in antidepressant doses Duloxetine is approved as both an antidepressant and for treatment of pain from diabetic neuropathy 27 NONOPIOID MEDICATION (2 of 2) • Antiepileptics such as gabapentin and pregabalin are commonly used for neuropathic pain • Corticosteroids are useful adjuvants for neuropathic pain and pain associated with swelling, inflammation, and tissue infiltration PAIN MEDICATIONS TO AVOID IN OLDER PEOPLE • Meperidine • Mixed agonist-antagonists such as nalbuphine and butorphanol • COX-2 inhibitors • Other NSAIDs ― use rarely, if ever 28 29 S U M M A RY ( 1 o f 2 ) • Pain requires a thorough assessment to determine its source, severity, and impact on the patient’s well-being • Cognitively impaired patients who cannot communicate about pain should receive empiric analgesia during procedures and conditions known to be painful • A stepped approach to pain treatment is advised, starting with local and nonpharmacologic approaches • Systemic analgesics should not be withheld if needed initially 30 S U M M A RY ( 2 o f 2 ) • In general, different opioids have similar efficacy and limited cross-tolerance • Patients being treated with opioids usually develop tolerance to the respiratory depression, fatigue, and sedation, but not to the constipating effect • Optimal analgesia requires treatment of any associated clinical depression • COX-2 inhibitors should be avoided in older patients, and nonselective NSAIDs should be used cautiously 31 CASE 1 (1 of 3) • A patient who lives in a nursing home is evaluated because his family is concerned that he has inadequately treated pain. • The patient has moderate dementia. 32 CASE 1 (2 of 3) How does pain assessment for patients with dementia differ from assessment for cognitively intact patients? A. Patients with dementia are less likely to report pain after activity. B. Patients with dementia are more likely to demonstrate pain behaviors, such as guarding or grimacing. C. Patients with dementia are more likely to express degree of pain by using a visual analogue pain scale. D. Patients with dementia are less likely to experience pain. 33 CASE 1 (3 of 3) How does pain assessment for patients with dementia differ from assessment for cognitively intact patients? A. Patients with dementia are less likely to report pain after activity. B. Patients with dementia are more likely to demonstrate pain behaviors, such as guarding or grimacing. C. Patients with dementia are more likely to express degree of pain by using a visual analogue pain scale. D. Patients with dementia are less likely to experience pain. 34 CASE 2 (1 of 4) • A 72-year-old woman comes to the office because for the past 6 months she has had severe burning pain in her feet that is worse at night. • She recently tried gabapentin but discontinued it because it caused gait disturbance. • History includes uncontrolled DM, chronic constipation, and mild cognitive impairment. 35 CASE 2 (2 of 4) • Medications include insulin glargine 20 units at night, lisinopril 20 mg/day, docusate sodium 100 mg q12h, metformin 1,000 mg q12h, and acetaminophen 1,000 mg q8h. • Her fingerstick glucose levels have been between 180 and 200 in the morning and in the mid-200s at night. 36 CASE 2 (3 of 4) Which of the following is the most appropriate next step for improving pain control? A. Increase insulin dosage. B. Refer for sympathectomy. C. Start lamotrigine. D. Start pregabalin. 37 CASE 2 (4 of 4) Which of the following is the most appropriate next step for improving pain control? A. Increase insulin dosage. B. Refer for sympathectomy. C. Start lamotrigine. D. Start pregabalin. 38 CASE 3 (1 of 3) • A 71-year-old woman comes to the office because she has pain from an osteoporotic vertebral fracture. • She is now receiving recommended therapy for osteoporosis. • The pain from the fracture prevents her from gardening. • Conservative measures—such as acetaminophen, physical therapy, and NSAIDs—have not provided adequate relief. 39 CASE 2 (2 of 3) Which of the following is the most appropriate recommendation for her pain? A. Vertebroplasty B. Oxycodone 2.5 mg orally q6h as needed C. Acetaminophen/hydrocodone 500/5 mg, 1 tablet orally q4h as needed D. Methadone 10 mg orally q8h E. Reiki therapy 40 CASE 2 (3 of 3) Which of the following is the most appropriate recommendation for her pain? A. Vertebroplasty B. Oxycodone 2.5 mg orally q6h as needed C. Acetaminophen/hydrocodone 500/5 mg, 1 tablet orally q4h as needed D. Methadone 10 mg orally q8h E. Reiki therapy 41 GNRS4 Teaching Slides Editor: Barbara Resnick, PhD, CRNP, FAAN, FAANP, AGSF GNRS4 Teaching Slides modified from GRS8 Teaching Slides based on chapter by VJ Periyakoil, MD and questions by Rachelle Bernancki, MD, MS Managing Editor: Andrea N. Sherman, MS Copyright © 2014 American Geriatrics Society SlideSlide 41 41
© Copyright 2026 Paperzz